BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home » Topics » Medical technology, Financings

Medical technology, Financings
Medical technology, Financings RSS Feed RSS

Financings for Jan. 18, 2023

Jan. 18, 2023
Med-tech firms raising money in public or private financings, including: Pathmaker.
Read More

Financings for Jan. 17, 2023

Jan. 17, 2023
Med-tech firms raising money in public or private financings, including: Pathmaker.
Read More

Financings for Jan. 13, 2023

Jan. 13, 2023
Med-tech firms raising money in public or private financings, including: HVR, Linusbio.
Read More
Volta Medical - VX1 AI software

Volta raises $39M to support US rollout of cardiac ablation software for complex arrhythmia

Jan. 12, 2023
By Bernard Banga
Volta Medical SAS reported raising $39 million in a series B round to roll out its VX1 software mapping system in Europe and the U.S. This artificial intelligence (AI) algorithm is compatible with most readily available multi-polar catheters and technology used in operating rooms and cath labs in the treatment of complex cardiac arrhythmia.
Read More

Financings for Jan. 12, 2023

Jan. 12, 2023
Med-tech firms raising money in public or private financings, including: Myomo, Pneumowave.
Read More

Financings for Jan. 11, 2023

Jan. 11, 2023
Med-tech firms raising money in public or private financings, including: Alume, Cari Health, Vero Biotech.
Read More

Financings for Jan. 10, 2023

Jan. 10, 2023
Med-tech firms raising money in public or private financings, including: Holmusk, Medix Infusion, Telesair, Veradigm.
Read More
Digital yuan illustration

Singular Medical closes series B+ financing to develop CRM products

Jan. 9, 2023
By Zhang Mengying
Suzhou Singular Medical Co. Ltd. has raised “hundreds of millions of RMB” in a series B+ round financing, which was jointly led by SDIC Chuanghe Fund Management Co. Ltd. and Qiming Venture Capital Management (Beijing) Co. Ltd. 
Read More

Financings for Jan. 9, 2023

Jan. 9, 2023
Med-tech firms raising money in public or private financings, including: Evosep Biosystems, Medx Health, Sonivie.
Read More

Skynor Medical nets $15M in financing for interventional procedures

Jan. 6, 2023
By Doris Yu
Skynor Medical (Shanghai) Co. Ltd. has raised ¥100 million (US$15 million) in a financing round to step up its efforts in product development and market expansion. More specifically, the Shanghai-based company intends to use the funds to develop its interventional treatment solutions for neuro and peripheral vascular diseases, as well as expand them to markets at home and abroad.
Read More
Previous 1 2 … 108 109 110 111 112 113 114 115 116 … 256 257 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Silhouette of head, brain

    Plasticity, properly parsed, provides psychiatric platform

    BioWorld
    If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing